J. Aart De Geus's most recent trade in Synopsys, Inc. was a trade of 1,764 Common Stock done . Disclosure was reported to the exchange on March 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 1,764 | 118,435 (0%) | 0% | 0 | Common Stock | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 1,764 | 3,526 | - | - | Restricted Stock Units | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 446.23 per share. | 15 Mar 2025 | 875 | 117,560 (0%) | 0% | 446.2 | 390,451 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 06 Mar 2025 | 15,705 | 132,376 (0%) | 0% | 89.8 | 1,409,681 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 15,705 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 444.42 per share. | 06 Mar 2025 | 15,705 | 116,671 (0%) | 0% | 444.4 | 6,979,652 | Common Stock |
| Applied Materials | Aart J. De Geus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 1,583 | 111,042 (0%) | 0% | 0 | Common Stock | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Other type of transaction at price $ 388.68 per share. | 28 Feb 2025 | 25 | 116,671 (0%) | 0% | 388.7 | 9,717 | Common Stock |
| Synopsys | J. Aart De Geus | Director, EXECUTIVE CHAIR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2024 | 7,323 | 7,323 | - | - | Non-Qualified Stock Option (right to buy) | |
| Synopsys | J. Aart De Geus | Director, EXECUTIVE CHAIR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2024 | 2,503 | 2,503 | - | - | Restricted Stock Units | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 11,408 | 0 | - | - | Restricted Stock Units | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 11,408 | 120,296 (0%) | 0% | 0 | Common Stock | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.28 per share. | 06 Dec 2024 | 5,657 | 114,639 (0%) | 0% | 517.3 | 2,926,253 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 3,736 | 1,868 | - | - | Restricted Stock Units | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 3,736 | 110,741 (0%) | 0% | 0 | Common Stock | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 1,868 | 116,507 (0%) | 0% | 0 | Common Stock | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 1,868 | 0 | - | - | Restricted Stock Units | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.28 per share. | 06 Dec 2024 | 1,853 | 108,888 (0%) | 0% | 517.3 | 958,520 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 1,234 | 1,234 | - | - | Restricted Stock Units | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 1,234 | 116,814 (0%) | 0% | 0 | Common Stock | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.28 per share. | 06 Dec 2024 | 927 | 115,580 (0%) | 0% | 517.3 | 479,519 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 882 | 2,645 | - | - | Restricted Stock Units | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 882 | 117,084 (0%) | 0% | 0 | Common Stock | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.28 per share. | 06 Dec 2024 | 612 | 116,202 (0%) | 0% | 517.3 | 316,575 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 517.28 per share. | 06 Dec 2024 | 438 | 116,646 (0%) | 0% | 517.3 | 226,569 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Other type of transaction at price $ 441.64 per share. | 30 Aug 2024 | 22 | 107,005 (0%) | 0% | 441.6 | 9,716 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Jul 2024 | 186,551 | 0 (0%) | 0% | 0 | Common Stock | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 620.60 per share. | 15 Jul 2024 | 493 | 106,983 (0%) | 0% | 620.6 | 305,954 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 15 Jul 2024 | 493 | 107,476 (0%) | 0% | 89.8 | 44,252 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2024 | 493 | 15,705 | - | - | Non-Qualified Stock Option (right to buy) | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 10 Jul 2024 | 8,648 | 115,631 (0%) | 0% | 89.8 | 776,244 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2024 | 8,648 | 20,786 | - | - | Non-Qualified Stock Option (right to buy) | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 620.29 per share. | 10 Jul 2024 | 8,648 | 106,983 (0%) | 0% | 620.3 | 5,364,265 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2024 | 4,588 | 16,198 | - | - | Non-Qualified Stock Option (right to buy) | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 621.68 per share. | 10 Jul 2024 | 4,588 | 106,983 (0%) | 0% | 621.7 | 2,852,273 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 10 Jul 2024 | 4,588 | 111,571 (0%) | 0% | 89.8 | 411,819 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 05 Jul 2024 | 27,753 | 134,736 (0%) | 0% | 89.8 | 2,491,109 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jul 2024 | 27,753 | 34,882 | - | - | Non-Qualified Stock Option (right to buy) | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 618.58 per share. | 05 Jul 2024 | 27,753 | 106,983 (0%) | 0% | 618.6 | 17,167,470 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jul 2024 | 5,448 | 29,434 | - | - | Non-Qualified Stock Option (right to buy) | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 620.95 per share. | 05 Jul 2024 | 5,448 | 106,983 (0%) | 0% | 620.9 | 3,382,929 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 05 Jul 2024 | 5,448 | 112,431 (0%) | 0% | 89.8 | 489,012 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 02 Jul 2024 | 4,340 | 111,323 (0%) | 0% | 89.8 | 389,558 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jul 2024 | 4,340 | 65,424 | - | - | Non-Qualified Stock Option (right to buy) | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 610.25 per share. | 02 Jul 2024 | 4,340 | 106,983 (0%) | 0% | 610.3 | 2,648,498 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jul 2024 | 2,789 | 62,635 | - | - | Non-Qualified Stock Option (right to buy) | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 610.94 per share. | 02 Jul 2024 | 2,789 | 106,983 (0%) | 0% | 610.9 | 1,703,912 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 02 Jul 2024 | 2,789 | 109,772 (0%) | 0% | 89.8 | 250,341 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 28 Jun 2024 | 11,185 | 118,168 (0%) | 0% | 89.8 | 1,003,966 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2024 | 11,185 | 75,657 | - | - | Non-Qualified Stock Option (right to buy) | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 603.94 per share. | 28 Jun 2024 | 11,185 | 106,983 (0%) | 0% | 603.9 | 6,755,057 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2024 | 5,893 | 69,764 | - | - | Non-Qualified Stock Option (right to buy) | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 602.00 per share. | 28 Jun 2024 | 5,893 | 106,983 (0%) | 0% | 602.0 | 3,547,564 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 28 Jun 2024 | 5,893 | 112,876 (0%) | 0% | 89.8 | 528,956 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2024 | 8,158 | 86,842 | - | - | Non-Qualified Stock Option (right to buy) | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 602.59 per share. | 26 Jun 2024 | 8,158 | 106,983 (0%) | 0% | 602.6 | 4,915,913 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 26 Jun 2024 | 8,158 | 115,141 (0%) | 0% | 89.8 | 732,262 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 26 Jun 2024 | 2,899 | 109,882 (0%) | 0% | 89.8 | 260,214 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2024 | 2,899 | 95,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 600.57 per share. | 26 Jun 2024 | 2,899 | 106,983 (0%) | 0% | 600.6 | 1,741,062 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2024 | 4,212 | 97,899 | - | - | Non-Qualified Stock Option (right to buy) | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 600.05 per share. | 24 Jun 2024 | 4,212 | 106,983 (0%) | 0% | 600.1 | 2,527,414 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 24 Jun 2024 | 4,212 | 111,195 (0%) | 0% | 89.8 | 378,069 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.76 per share. | 24 Jun 2024 | 2,535 | 109,518 (0%) | 0% | 89.8 | 227,542 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2024 | 2,535 | 102,111 | - | - | Non-Qualified Stock Option (right to buy) | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Sale of securities on an exchange or to another person at price $ 600.99 per share. | 24 Jun 2024 | 2,535 | 106,983 (0%) | 0% | 601.0 | 1,523,498 | Common Stock |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 1,764 | 107,593 (0%) | 0% | 0 | Common Stock | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Mar 2024 | 1,764 | 5,290 | - | - | Restricted Stock Units | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 550.03 per share. | 15 Mar 2024 | 610 | 106,983 (0%) | 0% | 550.0 | 335,518 | Common Stock |
| Applied Materials | Aart J. De Geus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 1,128 | 109,459 (0%) | 0% | 0 | Common Stock | |
| Synopsys | Aart J. De Geus | Director, EXECUTIVE CHAIR | Other type of transaction at price $ 261.55 per share. | 29 Feb 2024 | 38 | 105,829 (0%) | 0% | 261.6 | 9,939 | Common Stock |
| Synopsys | Aart J. De Geus | Director, Chairman of the Board & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2023 | 11,409 | 111,448 (0%) | 0% | 0 | Common Stock | |
| Synopsys | De Geus Aart J. | Director, Chairman of the Board & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2023 | 11,408 | 11,408 | - | - | Restricted Stock Units | |
| Synopsys | De Geus Aart J. | Director, Chairman of the Board & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2023 | 10,938 | 10,938 | - | - | Non-Qualified Stock Option (right to buy) | |
| Synopsys | De Geus Aart J. | Director, Chairman of the Board & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 567.06 per share. | 12 Dec 2023 | 5,657 | 105,791 (0%) | 0% | 567.1 | 3,207,858 | Common Stock |
| Synopsys | Aart J. De Geus | Director, Chairman of the Board & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2023 | 3,527 | 3,527 | - | - | Restricted Stock Units | |
| Synopsys | J. Aart De Geus | Director, Chairman of the Board & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 08 Dec 2023 | 4,231 | 0 | - | - | Restricted Stock Units | |
| Synopsys | J. Aart De Geus | Director, Chairman of the Board & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2023 | 4,231 | 98,690 (0%) | 0% | 0 | Common Stock | |
| Synopsys | De Geus J. Aart | Director, Chairman of the Board & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 08 Dec 2023 | 3,737 | 7,472 | - | - | Restricted Stock Units | |
| Synopsys | J. Aart De Geus | Director, Chairman of the Board & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2023 | 3,737 | 100,329 (0%) | 0% | 0 | Common Stock | |
| Synopsys | De Geus Aart J. | Director, Chairman of the Board & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 535.93 per share. | 08 Dec 2023 | 2,098 | 96,592 (0%) | 0% | 535.9 | 1,124,381 | Common Stock |
| Synopsys | Aart J. De Geus | Director, Chairman of the Board & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 08 Dec 2023 | 1,868 | 5,604 | - | - | Restricted Stock Units | |
| Synopsys | J. De Geus Aart | Director, Chairman of the Board & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2023 | 1,868 | 100,344 (0%) | 0% | 0 | Common Stock | |
| Synopsys | J. De Geus Aart | Director, Chairman of the Board & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 535.93 per share. | 08 Dec 2023 | 1,853 | 98,476 (0%) | 0% | 535.9 | 993,078 | Common Stock |
| Synopsys | De Geus J. Aart | Director, Chairman of the Board & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2023 | 1,234 | 100,651 (0%) | 0% | 0 | Common Stock | |
| Synopsys | De Geus J. Aart | Director, Chairman of the Board & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 08 Dec 2023 | 1,234 | 2,468 | - | - | Restricted Stock Units | |
| Synopsys | De Geus Aart J. | Director, Chairman of the Board & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 535.93 per share. | 08 Dec 2023 | 927 | 99,417 (0%) | 0% | 535.9 | 496,807 | Common Stock |
| Synopsys | Aart De Geus J. | Director, Chairman of the Board & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 535.93 per share. | 08 Dec 2023 | 612 | 100,039 (0%) | 0% | 535.9 | 327,989 | Common Stock |
| Synopsys | Aart J. De Geus | Director, Chairman of the Board & CEO | Sale of securities on an exchange or to another person at price $ 428.18 per share. | 21 Jun 2023 | 40,839 | 94,421 (0%) | 0% | 428.2 | 17,486,606 | Common Stock |
| Synopsys | Aart J. De Geus | Director, Chairman of the Board & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2023 | 40,839 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Synopsys | Aart J. De Geus | Director, Chairman of the Board & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 90.51 per share. | 21 Jun 2023 | 40,839 | 135,260 (0%) | 0% | 90.5 | 3,696,338 | Common Stock |
| Synopsys | Aart J. De Geus | Director, Chairman of the Board & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 90.51 per share. | 13 Jun 2023 | 40,000 | 134,421 (0%) | 0% | 90.5 | 3,620,400 | Common Stock |
| Synopsys | Aart J. De Geus | Director, Chairman of the Board & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2023 | 40,000 | 40,839 | - | - | Non-Qualified Stock Option (right to buy) | |
| Synopsys | Aart J. De Geus | Director, Chairman of the Board & CEO | Sale of securities on an exchange or to another person at price $ 447.40 per share. | 13 Jun 2023 | 40,000 | 94,421 (0%) | 0% | 447.4 | 17,896,136 | Common Stock |
| Synopsys | Aart J. De Geus | Director, Chairman of the Board & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 40,000 | 80,839 | - | - | Non-Qualified Stock Option (right to buy) | |
| Synopsys | Aart J. De Geus | Director, Chairman of the Board & CEO | Sale of securities on an exchange or to another person at price $ 445.42 per share. | 06 Jun 2023 | 40,000 | 94,421 (0%) | 0% | 445.4 | 17,816,820 | Common Stock |
| Synopsys | Aart J. De Geus | Director, Chairman of the Board & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 90.51 per share. | 06 Jun 2023 | 40,000 | 134,421 (0%) | 0% | 90.5 | 3,620,400 | Common Stock |
| Applied Materials | Aart J. De Geus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 2,050 | 108,331 (0%) | 0% | 0 | Common Stock | |
| Synopsys | Aart J. De Geus | Director, Chairman of the Board & CEO | Other type of transaction at price $ 261.55 per share. | 28 Feb 2023 | 38 | 94,421 (0%) | 0% | 261.6 | 9,939 | Common Stock |
| Synopsys | Aart J. De Geus | Director, Chairman of the Board & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 21,196 | 21,196 | - | - | Non-Qualified Stock Option (right to buy) | |
| Synopsys | Aart J. De Geus | Director, Chairman of the Board & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 7,054 | 7,054 | - | - | Restricted Stock Units |